 | • レポートコード：MRC2-11QY04387 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は前立腺がんのグローバル市場について調査・分析したレポートです。種類別（ホルモン感受性前立腺がん、ホルモン不応性前立腺がん）市場規模、用途別（化学療法、ホルモン療法、標的療法、免疫療法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別前立腺がんの競争状況、市場シェア ・世界の前立腺がん市場：種類別市場規模 2015年-2020年（ホルモン感受性前立腺がん、ホルモン不応性前立腺がん） ・世界の前立腺がん市場：種類別市場規模予測 2021年-2026年（ホルモン感受性前立腺がん、ホルモン不応性前立腺がん） ・世界の前立腺がん市場：用途別市場規模 2015年-2020年（化学療法、ホルモン療法、標的療法、免疫療法） ・世界の前立腺がん市場：用途別市場規模予測 2021年-2026年（化学療法、ホルモン療法、標的療法、免疫療法） ・北米の前立腺がん市場分析：米国、カナダ ・ヨーロッパの前立腺がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの前立腺がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の前立腺がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの前立腺がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas, Inc.、AstraZeneca plc、Johnson & Johnson、Sanofi S.A、Bristol Myers Squibb (BMS)、Bayer AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Prostate cancer is cancer that occurs in the prostate.
Market Analysis and Insights: Global Prostate Cancer Market
The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prostate Cancer Scope and Market Size
Prostate Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Astellas, Inc.
AstraZeneca plc
Johnson & Johnson
Sanofi S.A
Bristol Myers Squibb (BMS)
Bayer AG
…
Market segment by Type, the product can be split into
Hormone sensitive prostate cancer
Hormone refractory prostate cancer
Market segment by Application, split into
Chemotherapy
Hormonal Therapy
Targeted Therapy
Immunotherapy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Revenue
1.4 Market by Type
1.4.1 Global Prostate Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hormone sensitive prostate cancer
1.4.3 Hormone refractory prostate cancer
1.5 Market by Application
1.5.1 Global Prostate Cancer Market Share by Application: 2020 VS 2026
1.5.2 Chemotherapy
1.5.3 Hormonal Therapy
1.5.4 Targeted Therapy
1.5.5 Immunotherapy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Market Perspective (2015-2026)
2.2 Global Prostate Cancer Growth Trends by Regions
2.2.1 Prostate Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Prostate Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prostate Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Players by Market Size
3.1.1 Global Top Prostate Cancer Players by Revenue (2015-2020)
3.1.2 Global Prostate Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Cancer Market Concentration Ratio
3.2.1 Global Prostate Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Revenue in 2019
3.3 Prostate Cancer Key Players Head office and Area Served
3.4 Key Players Prostate Cancer Product Solution and Service
3.5 Date of Enter into Prostate Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prostate Cancer Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Prostate Cancer Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prostate Cancer Market Size (2015-2020)
6.2 Prostate Cancer Key Players in North America (2019-2020)
6.3 North America Prostate Cancer Market Size by Type (2015-2020)
6.4 North America Prostate Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prostate Cancer Market Size (2015-2020)
7.2 Prostate Cancer Key Players in Europe (2019-2020)
7.3 Europe Prostate Cancer Market Size by Type (2015-2020)
7.4 Europe Prostate Cancer Market Size by Application (2015-2020)
8 China
8.1 China Prostate Cancer Market Size (2015-2020)
8.2 Prostate Cancer Key Players in China (2019-2020)
8.3 China Prostate Cancer Market Size by Type (2015-2020)
8.4 China Prostate Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prostate Cancer Market Size (2015-2020)
9.2 Prostate Cancer Key Players in Japan (2019-2020)
9.3 Japan Prostate Cancer Market Size by Type (2015-2020)
9.4 Japan Prostate Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prostate Cancer Market Size (2015-2020)
10.2 Prostate Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Cancer Market Size by Application (2015-2020)
11 India
11.1 India Prostate Cancer Market Size (2015-2020)
11.2 Prostate Cancer Key Players in India (2019-2020)
11.3 India Prostate Cancer Market Size by Type (2015-2020)
11.4 India Prostate Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prostate Cancer Market Size (2015-2020)
12.2 Prostate Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Cancer Market Size by Type (2015-2020)
12.4 Central & South America Prostate Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Astellas, Inc.
13.1.1 Astellas, Inc. Company Details
13.1.2 Astellas, Inc. Business Overview
13.1.3 Astellas, Inc. Prostate Cancer Introduction
13.1.4 Astellas, Inc. Revenue in Prostate Cancer Business (2015-2020))
13.1.5 Astellas, Inc. Recent Development
13.2 AstraZeneca plc
13.2.1 AstraZeneca plc Company Details
13.2.2 AstraZeneca plc Business Overview
13.2.3 AstraZeneca plc Prostate Cancer Introduction
13.2.4 AstraZeneca plc Revenue in Prostate Cancer Business (2015-2020)
13.2.5 AstraZeneca plc Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Prostate Cancer Introduction
13.3.4 Johnson & Johnson Revenue in Prostate Cancer Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Sanofi S.A
13.4.1 Sanofi S.A Company Details
13.4.2 Sanofi S.A Business Overview
13.4.3 Sanofi S.A Prostate Cancer Introduction
13.4.4 Sanofi S.A Revenue in Prostate Cancer Business (2015-2020)
13.4.5 Sanofi S.A Recent Development
13.5 Bristol Myers Squibb (BMS)
13.5.1 Bristol Myers Squibb (BMS) Company Details
13.5.2 Bristol Myers Squibb (BMS) Business Overview
13.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Introduction
13.5.4 Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2015-2020)
13.5.5 Bristol Myers Squibb (BMS) Recent Development
13.6 Bayer AG
13.6.1 Bayer AG Company Details
13.6.2 Bayer AG Business Overview
13.6.3 Bayer AG Prostate Cancer Introduction
13.6.4 Bayer AG Revenue in Prostate Cancer Business (2015-2020)
13.6.5 Bayer AG Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Prostate Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Cancer Revenue
Table 3. Ranking of Global Top Prostate Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hormone sensitive prostate cancer
Table 6. Key Players of Hormone refractory prostate cancer
Table 7. Global Prostate Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Prostate Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Prostate Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Prostate Cancer Market Share by Regions (2015-2020)
Table 11. Global Prostate Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Prostate Cancer Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Prostate Cancer Market Growth Strategy
Table 17. Main Points Interviewed from Key Prostate Cancer Players
Table 18. Global Prostate Cancer Revenue by Players (2015-2020) (Million US$)
Table 19. Global Prostate Cancer Market Share by Players (2015-2020)
Table 20. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer as of 2019)
Table 21. Global Prostate Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Prostate Cancer Product Solution and Service
Table 24. Date of Enter into Prostate Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 27. Global Prostate Cancer Market Size Share by Type (2015-2020)
Table 28. Global Prostate Cancer Revenue Market Share by Type (2021-2026)
Table 29. Global Prostate Cancer Market Size Share by Application (2015-2020)
Table 30. Global Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 31. Global Prostate Cancer Market Size Share by Application (2021-2026)
Table 32. North America Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Prostate Cancer Market Share (2019-2020)
Table 34. North America Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 35. North America Prostate Cancer Market Share by Type (2015-2020)
Table 36. North America Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 37. North America Prostate Cancer Market Share by Application (2015-2020)
Table 38. Europe Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Prostate Cancer Market Share (2019-2020)
Table 40. Europe Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Prostate Cancer Market Share by Type (2015-2020)
Table 42. Europe Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Prostate Cancer Market Share by Application (2015-2020)
Table 44. China Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 45. China Key Players Prostate Cancer Market Share (2019-2020)
Table 46. China Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 47. China Prostate Cancer Market Share by Type (2015-2020)
Table 48. China Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 49. China Prostate Cancer Market Share by Application (2015-2020)
Table 50. Japan Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Prostate Cancer Market Share (2019-2020)
Table 52. Japan Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Prostate Cancer Market Share by Type (2015-2020)
Table 54. Japan Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Prostate Cancer Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Prostate Cancer Market Share (2019-2020)
Table 58. Southeast Asia Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Prostate Cancer Market Share by Type (2015-2020)
Table 60. Southeast Asia Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Prostate Cancer Market Share by Application (2015-2020)
Table 62. India Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 63. India Key Players Prostate Cancer Market Share (2019-2020)
Table 64. India Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 65. India Prostate Cancer Market Share by Type (2015-2020)
Table 66. India Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 67. India Prostate Cancer Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Prostate Cancer Market Share (2019-2020)
Table 70. Central & South America Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Prostate Cancer Market Share by Type (2015-2020)
Table 72. Central & South America Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Prostate Cancer Market Share by Application (2015-2020)
Table 74. Astellas, Inc. Company Details
Table 75. Astellas, Inc. Business Overview
Table 76. Astellas, Inc. Product
Table 77. Astellas, Inc. Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 78. Astellas, Inc. Recent Development
Table 79. AstraZeneca plc Company Details
Table 80. AstraZeneca plc Business Overview
Table 81. AstraZeneca plc Product
Table 82. AstraZeneca plc Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 83. AstraZeneca plc Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Product
Table 87. Johnson & Johnson Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 88. Johnson & Johnson Recent Development
Table 89. Sanofi S.A Company Details
Table 90. Sanofi S.A Business Overview
Table 91. Sanofi S.A Product
Table 92. Sanofi S.A Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 93. Sanofi S.A Recent Development
Table 94. Bristol Myers Squibb (BMS) Company Details
Table 95. Bristol Myers Squibb (BMS) Business Overview
Table 96. Bristol Myers Squibb (BMS) Product
Table 97. Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 98. Bristol Myers Squibb (BMS) Recent Development
Table 99. Bayer AG Company Details
Table 100. Bayer AG Business Overview
Table 101. Bayer AG Product
Table 102. Bayer AG Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 103. Bayer AG Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Market Share by Type: 2020 VS 2026
Figure 2. Hormone sensitive prostate cancer Features
Figure 3. Hormone refractory prostate cancer Features
Figure 4. Global Prostate Cancer Market Share by Application: 2020 VS 2026
Figure 5. Chemotherapy Case Studies
Figure 6. Hormonal Therapy Case Studies
Figure 7. Targeted Therapy Case Studies
Figure 8. Immunotherapy Case Studies
Figure 9. Prostate Cancer Report Years Considered
Figure 10. Global Prostate Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Prostate Cancer Market Share by Regions: 2020 VS 2026
Figure 12. Global Prostate Cancer Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Prostate Cancer Market Share by Players in 2019
Figure 15. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Revenue in 2019
Figure 17. North America Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …- 前立腺がん治療の世界市場（～2026年） Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race. Market Analysis and Insights: Global Prostate Cancer Treatment Market The global Prostate Cancer Treatment market size is projected to reach US$ XX m…
- 去勢抵抗性前立腺がん治療の世界市場（～2026年） Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose a…
- 前立腺がん治療薬の世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise…
- 前立腺がんバイオマーカーの世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. Market Analysis and Insights: Global Prostate Cancer Biomarker Market The gl…